Solutions · By function

AI transformation, function by function.

Every function gets the same three stages — Advise, Build, Run — sized to its regulatory exposure and value at stake.

R&D

Discovery & research

AdviseUse-case scan across target ID, biologics design, lab automation.

BuildAgent orchestration over structure models and self-driving lab data.

RunMonitoring + retraining as proprietary assay data accumulates.

CLIN

Clinical operations

AdviseMap agent leverage across feasibility, protocol, eTMF, query.

BuildConnective-tissue agents from literature → protocol → site → data.

RunReviewer ops + drift detection across studies and sites.

REG

Regulatory submissions

AdviseSubmission portfolio triage, value-at-stake by program.

BuildDossier assembly, cross-reference checks, response drafting agents.

RunAudit trails, version control, regulator-facing change logs.

PV

Pharmacovigilance

AdviseCase intake redesign around agent + human reviewer model.

BuildAE intake, case triage, narrative drafting, signal detection.

Run24/7 monitoring with strict escalation and reviewer SLAs.

MA

Medical affairs

AdviseInsight strategy across congress, social, ad-boards, CRM.

BuildMulti-agent synthesis from "what" to "why" with provenance.

RunMSL field briefings and ad-board pre-reads as a running service.

MC

Medical communications

AdvisePublication portfolio and plain-language summary strategy.

BuildDrafting agents with pre-MLR validation at the moment of authoring.

RunGoverned authoring environment, MLR-ready, with full lineage.

MI

Medical information

AdviseSRD coverage and HCP-inquiry workload mapping.

BuildInquiry handling agents against approved evidence.

RunHuman-in-the-loop response queue with audit-grade trails.

COM

Commercial & omnichannel

AdviseWhere agents create margin vs. where they commoditize.

BuildPlanning agents, omnichannel content, MLR automation.

RunPerformance ops + governance for promotional content under FDA scrutiny.

Not sure where to start?

A two-week opportunity scan ranks workloads across your portfolio by value and feasibility. You leave with a build plan, not a deck.

See the platform